, Tracking Stock Market Picks
Enter Symbol:
Mannkind Corporation (MNKD) [hlAlert]

up 268.31 %

Mannkind Corporation (MNKD) rated Buy by BofA/Merrill

Posted on: Monday,  Nov 5, 2012  8:25 AM ET by BofA/Merrill

BofA/Merrill rated Buy Mannkind Corporation (NASDAQ: MNKD) on 11/05/2012, when the stock price was $2.02. Since then, Mannkind Corporation
has gained 268.32% of its value until BofA/Merrill rated MNKD Neutral on 06/07/2013, when the price was $7.44.
If you would have followed this BofA/Merrill's recommendation on MNKD, you would have gained 268.31% of your investment in 214 days.

Mannkind Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for diseases such as diabetes, cancer, inflammatory and autoimmune diseases. The Company's lead product, the Technosphere Insulin System, consists of the Company's dry-powder Technosphere formulation of insulin and the Company's MedTone inhaler through which the powder is inhaled into the deep lung.

Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/6/2013 8:25 AM Sell
as of 12/31/2012
1 Week up  5.00 %
1 Month up  8.45 %
3 Months up  14.35 %
1 YTD up  14.35 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
6/7/2013 8:25 AM Hold
11/5/2012 8:25 AM Buy

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy